Publications by authors named "Masaaki Noguchi"

Article Synopsis
  • The study aimed to evaluate the effectiveness and safety of venetoclax plus azacitidine (VEN+AZA) in treating patients with acute myeloid leukemia (AML), considering factors affecting treatment success and continuation.
  • In a review of 39 patients, the results showed a 61.5% rate of composite complete remission, with median overall survival at 7.7 months and significant treatment discontinuation at 76.9%.
  • The findings highlighted that better outcomes were correlated with factors like lower cytogenetic risk and appropriate treatment timing, underscoring the importance of selecting suitable candidates for this treatment to enhance prognosis.
View Article and Find Full Text PDF

Aggressive mature T-cell lymphoma (TCL) is a disease that carries a poor prognosis. We analyzed the expression of 22 tumor cell functional proteins in 16 randomly selected patients with TCL. Immunohistochemistry was performed in paraffin-embedded tumor tissue sections to determine the protein expression statuses in tumor cells.

View Article and Find Full Text PDF

It has been about 40 years since I graduated from Juntendo University School of Medicine in 1983. For 5 years after graduation, I was engaged in research on glycolipids in the Biochemistry Unit of the University of Tokyo. Later, I wrote and published papers on glycolipids.

View Article and Find Full Text PDF
Article Synopsis
  • An 84-year-old woman was diagnosed with acute promyelocytic leukemia (APL) and initially treated with all-trans retinoic acid (ATRA), achieving complete hematological remission.
  • After refusing consolidation therapy, she experienced a hematological relapse and was treated with arsenite (ATO), resulting in complete molecular remission.
  • Following further relapses and treatments, including tamibarotene and a combination of venetoclax and azacitidine, she ultimately succumbed to gastrointestinal hemorrhage, highlighting the complexities of treating CD56-positive APL resistant to standard therapies.
View Article and Find Full Text PDF

We conducted a retrospective analysis of GRP94 immunohistochemical (IHC) staining, an ER stress protein, on large B-cell lymphoma (LBCL) cells, intracellular p53, and 15 factors involved in the metabolism of the CHOP regimen: AKR1C3 (HO metabolism), CYP3A4 (CHOP metabolism), and HO efflux pumps (MDR1 and MRP1). The study subjects were 42 patients with LBCL at our hospital. The IHC staining used antibodies against the 17 factors.

View Article and Find Full Text PDF

Aims: Tissue eosinophilia is commonly observed in T-cell and classic Hodgkin lymphomas, but rarely in B-cell lymphomas. Herein, we present the first report of a case series on nodal marginal zone lymphoma (NMZL) with tissue eosinophilia.

Methods And Results: All 11 patients in this study had nodal disease at primary presentation.

View Article and Find Full Text PDF

We conducted this study with the objective of elucidating the mechanism of development of fibrosis in hematologic neoplasms and develop treatments for these patients. Among the suggested mechanisms of development of fibrosis is cases of hematologic neoplasms is the production of TGF-beta1 (transforming growth factor-beta-1) and TNF-alpha1 (tumor necrotizing factor-alpha-1) by the tumor cells, both of which are fibrosis-stimulating cytokines that act on fibroblasts to promote fibrosis. However, there are few reports based on human clinical pathology studies.

View Article and Find Full Text PDF

Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) is a rare disease, which presents with features of myelodysplastic syndromes with ring sideroblasts and essential thrombocythemia, as well as anemia and marked thrombocytosis. SF3B1 and JAK2 mutations are often found in patients, and are associated with their specific clinical features. This study was a retrospective analysis of 34 Japanese patients with MDS/MPN-RS-T.

View Article and Find Full Text PDF

TAFRO syndrome is a rare systemic inflammatory disease characterized by thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly. We encountered a case of calreticulin mutation-positive essential thrombocythemia (ET) with TAFRO syndrome-like features, followed by a rapid fatal course. The patient had been on anagrelide therapy for approximately three years for management of ET; however, she suddenly stopped going for follow-up and discontinued the medicine for a year.

View Article and Find Full Text PDF
Article Synopsis
  • This study assesses prognostic factors for patients with hematological malignancies receiving end-of-life chemotherapy, emphasizing the need for clinicians to make informed treatment decisions.
  • The research involved a retrospective review of 247 patient records, focusing on 82 patients who received chemotherapy in their last treatment phase, analyzing several prognostic tools like the Palliative Prognostic Index (PPI).
  • Key findings indicate that higher PPI scores and older age (≥ 65 years) are correlated with reduced overall survival, suggesting that using the PPI can guide more effective end-of-life care discussions between patients and healthcare providers.
View Article and Find Full Text PDF
Article Synopsis
  • Many patients with primary vitreoretinal lymphoma (PVRL) often show symptoms related to the central nervous system (CNS) either at diagnosis or later on.
  • The prognosis is generally very poor for those with recurrent or hard-to-treat CNS involvement.
  • However, a case is reported where a patient with refractory PVRL had a notable but temporary response to tirabrutinib after already undergoing standard treatments, indicating potential benefits of this new targeted therapy.
View Article and Find Full Text PDF

Histiocytes and dendritic cells may display cytological atypia and an aberrant immunophenotype even in reactive processes. Herein, we describe two cases of "Hodgkinoid histiocytosis" that show distinctive clinicopathological features, mimicking morphologically classic Hodgkin lymphoma (CHL), but suggesting reactive histiocytic/dendritic cell proliferation in lymph nodes. Both the patients presented with peripheral lymphadenopathy and blood eosinophilia with skin manifestations.

View Article and Find Full Text PDF

Neuroendocrine neoplasms are rare epithelial neoplasms with neuroendocrine differentiation. Few cases of primary testicular poorly differentiated neuroendocrine carcinomas (PD-NECs) have been reported, and secondary testicular neoplasms are rare. A 61-year-old man with a chief complaint of left testicular swelling was referred to our hospital.

View Article and Find Full Text PDF

A 76-year-man presented with generalized lymphadenopathy. Lymph node biopsy led to the diagnosis of Epstein-Barr virus-encoded small RNA in situ hybridization (EBER)-positive angioimmunoblastic T-cell lymphoma (AITL). He was initiated on treatment with oral prednisolone (PSL) at the dose of 50 mg/day; however, he was diagnosed as having right pleural effusion.

View Article and Find Full Text PDF

Although a previous autopsy series demonstrated that pulmonary leukemic infiltration (PLI) is a major pulmonary complication in patients with acute myeloid leukemia (AML), an antemortem diagnosis of PLI is rare. Diverse pulmonary complications cause acute respiratory failure (ARF) in patients with AML undergoing chemotherapy. This article reports two elderly patients with AML who presented with ARF due to PLI mimicking severe pneumonia during induction chemotherapy.

View Article and Find Full Text PDF

Background: Secondary hemophagocytic lymphohistiocytosis (sHLH) is a rare and fatal disease characterized by uncontrolled immune cell activation that can lead to a cytokine storm. Unfortunately, this condition can occur even during pregnancy, threatening both maternal and fetal lives.

Case Presentation: A 23-year-old nulliparous woman at 26 weeks of gestation presented with continuous fever, coughing, and sore throat.

View Article and Find Full Text PDF
Article Synopsis
  • * Out of 190 patients, 13.2% exhibited overlapping GI lesions across multiple segments, with the highest rates observed in mantle cell lymphomas (100%), follicular lymphomas (27.6%), and diffuse large B-cell lymphomas (16.3%).
  • * The findings recommend thorough examination of the entire GI tract using various endoscopic methods, particularly for patients with MCL, FL, and DLBCL, where overlapping lesions were prevalent.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of the Palliative Prognostic Index (PPI) in predicting the prognosis of hospitalized patients with advanced hematologic malignancies, since most prognostic models focus on solid tumors.
  • A retrospective review of 143 patients who were resistant to chemotherapy revealed significant differences in median overall survival times across three PPI score groups, indicating that PPI can accurately gauge survival for these patients.
  • The findings validate the PPI's usefulness for near-end-of-life patients with hematologic malignancies, suggesting it can help inform treatment decisions in this population.
View Article and Find Full Text PDF

Unlabelled: In Japan, ibrutinib has been approved as both a front-line and later-line treatment for chronic leukemia/small lymphocytic lymphoma(CLL/SLL). However, little is known about the actual outcomes and adverse events(AEs)associated with the use of ibrutinib in Japanese patients.

Objective: The outcomes and AEs of patients treated with ibrutinib in a real-world setting were investigated.

View Article and Find Full Text PDF

Background And Aims: In gastrointestinal neuroendocrine tumors (GI-NETs), tumor size and grading based on cellular proliferative ability indicate biological malignancy but not necessarily clinically efficient prognostic stratification. We analyzed tumor size- and grading-based prevalence of lymphovascular invasion in GI-NETs to establish whether these are true biological malignancy indicators.

Methods: We included 155 cases (165 lesions), diagnosed histologically with GI-NETs, that had undergone endoscopic or surgical resection.

View Article and Find Full Text PDF

A 42‒year‒old woman. At week 27 of pregnancy, she developed subcortical hemorrhage and underwent open cranial surgery for hematoma evacuation. The platelet(Plt)count was 297,000/μL.

View Article and Find Full Text PDF

Lymphoma-associated hemophagocytic lymphohistiocytosis (HLH) has a significantly poor prognosis among secondary HLH. We describe the rare case of a 74-year-old female with secondary HLH presenting with a rapidly fatal course. Post-mortem examination revealed Epstein-Barr virus (EBV) -positive diffuse large B-cell lymphoma (DLBCL).

View Article and Find Full Text PDF

Primary skeletal muscle lymphoma is extremely uncommon, and there have only been eight previous case reports on primary skeletal muscle peripheral T-cell lymphoma, not otherwise specified (PSM-PTCL, NOS). We herein report an autopsy case of a 71-year-old woman with PSM-PTCL, NOS, who had a 24-year history of systemic sclerosis treated with immunosuppressive drugs. A post-mortem examination revealed infiltration of lymphoma cells positive for T-cell markers, cytotoxic markers, and p53.

View Article and Find Full Text PDF

Background: Surgery is recommended for patients with high-risk submucosal invasive rectal cancer (SM-RC) after local resection but affects the quality of life due to stoma placement or impaired anal function; therefore, alternative treatment approaches are needed to prevent local metastasis. The purpose of this study was to assess the short-term safety of adjuvant chemoradiotherapy with capecitabine in patients with high-risk submucosal invasive rectal cancer after local resection.

Methods: This single-arm, multicenter, phase II trial included patients undergoing local resection for high-risk submucosal invasive rectal cancer within 12 weeks prior to enrollment.

View Article and Find Full Text PDF